Calcium channel blocker: Difference between revisions
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
|- | |- | ||
|[[Amlodipine/ja]] | |[[Amlodipine/ja]] | ||
|ノルバスク(Norvasc) ([https://pins.japic.or.jp/pdf/newPINS/00058792.pdf PI]) ([https://www.viatris-e-channel.com/viatris-products/di/pdf/nor01if.pdf IF]) | |[https://www.viatris-e-channel.com/viatris-products/di/detail/4987901008808.html ノルバスク](Norvasc) ([https://pins.japic.or.jp/pdf/newPINS/00058792.pdf PI]) ([https://www.viatris-e-channel.com/viatris-products/di/pdf/nor01if.pdf IF]) | ||
|販売 | |販売 | ||
|[[Pfizer]] | |[[Pfizer]] | ||
| Line 23: | Line 23: | ||
|- | |- | ||
|[[Azelnidipine/ja]] | |[[Azelnidipine/ja]] | ||
|カルブロック(Calblock) ([https://pins.japic.or.jp/pdf/newPINS/00049335.pdf PI]) ([https://www.medicalcommunity.jp/filedsp/products$druginfo$calblock$if/field_file_pdf IF]) | |[https://www.medicalcommunity.jp/products/druginfo/calblock_tablets_16mg カルブロック](Calblock) ([https://pins.japic.or.jp/pdf/newPINS/00049335.pdf PI]) ([https://www.medicalcommunity.jp/filedsp/products$druginfo$calblock$if/field_file_pdf IF]) | ||
|販売 | |販売 | ||
|[[Daiichi Sankyo|三共]] | |[[Daiichi Sankyo|三共]] | ||
| Line 29: | Line 29: | ||
|- | |- | ||
|[[Barnidipine/ja]] | |[[Barnidipine/ja]] | ||
|ヒポカ(Hypoca) ([https://pins.japic.or.jp/pdf/newPINS/00004632.pdf PI]) ([https://www.ltl-pharma.com/common/pdf/product/hypoca/hypoca_op.pdf IF]) | |[https://www.ltl-pharma.com/product/hypoca.php ヒポカ](Hypoca) ([https://pins.japic.or.jp/pdf/newPINS/00004632.pdf PI]) ([https://www.ltl-pharma.com/common/pdf/product/hypoca/hypoca_op.pdf IF]) | ||
|販売 | |販売 | ||
|[[Astellas Pharma|山之内製薬]] | |[[Astellas Pharma|山之内製薬]] | ||
| Line 35: | Line 35: | ||
|- | |- | ||
|[[Benidipine/ja]] | |[[Benidipine/ja]] | ||
|コニール(Coniel) ([https://pins.japic.or.jp/pdf/newPINS/00005939.pdf PI]) ([https://image.packageinsert.jp/pdf.php?mode=1&yjcode=2171021F1024 IF]) | |[https://medical.kyowakirin.co.jp/druginfo/detail/coniel-tablets-4/index.html コニール](Coniel) ([https://pins.japic.or.jp/pdf/newPINS/00005939.pdf PI]) ([https://image.packageinsert.jp/pdf.php?mode=1&yjcode=2171021F1024 IF]) | ||
|販売 | |販売 | ||
|[[Kyowa Kirin|協和キリン]] | |[[Kyowa Kirin|協和キリン]] | ||
| Line 41: | Line 41: | ||
|- | |- | ||
|[[Cilnidipine/ja]] | |[[Cilnidipine/ja]] | ||
|アテレック(Atelec) ([https://pins.japic.or.jp/pdf/newPINS/00062065.pdf PI]) ([https://med.mochida.co.jp/interview/atc_n29.pdf IF]) | |[https://med.mochida.co.jp/index/atc-h.html アテレック](Atelec) ([https://pins.japic.or.jp/pdf/newPINS/00062065.pdf PI]) ([https://med.mochida.co.jp/interview/atc_n29.pdf IF]) | ||
|販売 | |販売 | ||
|[[:ja:富士レビオ|富士レビオ]]<br/>[[:ja:味の素|味の素]] | |[[:ja:富士レビオ|富士レビオ]]<br/>[[:ja:味の素|味の素]] | ||
| Line 47: | Line 47: | ||
|- | |- | ||
|[[Efonidipine/ja]] | |[[Efonidipine/ja]] | ||
|ランデル | |[https://medical.zeria.co.jp/di/landel/index.html ランデル](Landel) ([https://pins.japic.or.jp/pdf/newPINS/00046949.pdf PI]) ([https://medical.zeria.co.jp/di/landel/pdf/ランデル錠10・20・40_インタビューフォーム.pdf IF]) | ||
| | |販売 | ||
| | |[[Nissan Chemical Corporation|日産化学]] | ||
| | | | ||
|- | |- | ||